FREMONT, Calif., Jan. 31, 2017 -- MEDABLE Inc. has been recognized as one of the Top 10 Analytics Solution Providers by Pharma Tech Outlook Magazine.
|
|||
“We take pride in honoring MEDABLE as one among the 10 companies that are specialized in providing Analytics solutions for Pharmaceutical Companies,” said Stacey Smith, Managing Editor of Pharma Tech Outlook. “Medable is the most secure platform in healthcare and the only globally compliant cloud solution in healthcare.”
Medable provides the fastest path to a HIPAA compliant healthcare application. Medable's platform provides all the healthcare applications features with the flexibility to support customer’s creative vision.
About MEDABLE
Medable is a privately held company based in Palo Alto. Medable’s products enable healthcare innovation. Medable Cortex is the fastest path to scalable, interoperable, HIPAA compliant applications. Medable Axon is the world's first SmartStudy technology that enables health experts to directly create and launch applications. Medable Cerebrum enables secure analytics across Medable apps on Cortex, Axon or third party backend systems for real-time algorithm-driven patient monitoring and health data visualization. For more info, visit: www.medable.com
About Pharma Tech Outlook
Published from Fremont, California, Pharma Tech Outlook is a print magazine that covers most important and latest developments in pharmaceutical industry. A panel of experts and members of Pharma Tech Outlook’s editorial board selected and finalized the “Top 10 Analytics Solution Providers 2017” and shortlisted the best vendors and consultants. For more info: www.pharmatechoutlook.com
Gary Poole, PR Director [email protected]


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



